Researchers are excited about Retatrutide , a novel dual treatment showing significant data in initial trials for body loss . It works by targeting both hormones : GLP-1 and GIP, which , when activated , https://jasonthgi677585.actoblog.com/41646461/this-new-prospect-for-body-reduction